Implementing WHO recommendations for NGS in Drug-Resistant Tuberculosis (DR-TB) can seem like a complex journey. Looking for clarity and a clear path forward?

This webinar is part of a six-part webinar series which provides a practical roadmap and real-world guidance by showcasing the implementation journeys of pioneering national TB programs integrating targeted NGS into their TB testing algorithms. In this webinar, South Africa - in the scaling phase, will share their experience of pioneering their national TB program.

This focused 30-minute webinar delivers specific stories and lessons learned aligned with these implementation stages, offering a comprehensive understanding of the process and the tangible impact of NGS on DR-TB control.

Gain practical insights to accelerate your End TB goals by learning directly from the pioneering experts leading this transformative change. Ready to translate WHO recommendations into actionable strategies? Register now for the whole six-part webinar series.

In this series, you will discover:

• The key drivers and infrastructure considerations for adopting tNGS in diverse national settings.
• Understanding of national models for NGS-enhanced TB testing algorithms.
• Real-world impact and best practices for successful tNGS implementation.

Speakers:

Dr Shaheed Vally Omar Centre Head, Centre for Tuberculosis, National Institute for Communicable Diseases (NICD) National Institute for Communicable Diseases (NICD), South Africa A Medical Scientist, with a research focus on Mycobacterium tuberculosis with over 15 years’ experience. Currently serving as the Head of the Centre for Tuberculosis at the National Institute for Communicable Diseases a division of the National Health Laboratory Service in South Africa. Further he oversees operations encompassing the National & WHO Supranational TB Reference Laboratories. He has been instrumental in advancing diagnostic evaluations and laboratory interpretative criteria for drug resistance determination. His current research focus is directed to improving national surveillance methodologies through the adept application of next-generation sequencing techniques. His contributions transcend laboratory confines, as he actively shapes national and global policy guidance pertaining to tuberculosis management. His direction has facilitated the seamless implementation of cutting-edge TB diagnostics into the routine laboratory, thereby strengthening standard practices and augmenting the efficacy of tuberculosis control measures.